계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Cadent Therapeutics
company
About
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $5.40M
- Industries
- Biotechnology,Health Care,Medical Device,Therapeutics,Wellness
- Founded date
- Jan 1, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, and novel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$5.40M
Cadent Therapeutics has raised a total of
$5.40M
in funding over 2 rounds. Their latest funding was raised on
Feb 16, 2012 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 16, 2012 | Series A | $5.40M | 1 |
Access BridgeGap Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Cadent Therapeutics is funded by 1 investors.
Access BridgeGap Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Access BridgeGap Ventures
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
